According to FutureWise analysis, the market for Age Related Macular Degeneration Drug is estimated to be US$ 11.29 billion in 2023 and is expected to reach US$ 19.57 billion by 2031 at a CAGR of 7.1% over the forecast period of 2025-2033.. Age-related macular degeneration (AMD) is a prevalent eye condition that primarily affects older adults, leading to blurred central vision due to damage to...